Trade News Today — August 29, 2026
Opinion: Dolly Parton was underestimated for decades. That became one of her greatest strengths and more — today's trade signal.
Markets are navigating a complex landscape of technological advancements, geopolitical developments, and shifting investor perceptions. On the corporate front, Microsoft's stock is on a roll, with its longest winning streak of the year, as concerns over AI software seem to be dissipating. Meanwhile, Nvidia's revenue forecast has left Wall Street stunned, sparking speculation about the potential role of Elon Musk's SpaceX in driving the chipmaker's growth. The tech sector's resilience is a welcome sign for investors, especially as they weigh the benefits and risks of AI applications in areas like healthcare, where the technology is being explored to help consumers choose Medicare plans.
Beyond the tech sphere, global politics and economics are also making headlines. Former US President Donald Trump has announced a deal with Venezuela to tap into the country's vast oil reserves, a move that could have significant implications for the global energy market. In the US, Federal Reserve officials like Kevin Warsh are working to maintain market trust, with Warsh benefiting from a bond market that appears to have confidence in his words. These developments highlight the interconnected nature of global markets, where technological innovation, geopolitics, and economic policy are constantly influencing each other.
Today's signal:
• Opinion: Dolly Parton was underestimated for decades. That became one of her greatest strengths (cnbc.com)
• Trump announces deal with Venezuela to secure more than 65 billion barrels of oil reserves (cnbc.com)
• Microsoft’s stock seals its longest winning streak of the year as AI software fears fade (marketwatch.com)
• Nvidia’s revenue forecast is so huge that Wall Street wonders if SpaceX is the reason (marketwatch.com)
• Kevin Warsh gets what every Fed chair hopes for: a bond market that trusts his word (marketwatch.com)
• AI wants to help you pick a Medicare plan. Should you let it? (marketwatch.com)